PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 22, 2024JAMA6 citations

Advancing Access to Cell and Gene Therapies in Medicaid

View Full Paper
JKJoseph T. KannarkatIHInmaculada HernandezNPNatasha Parekh

Key Points

Key points are not available for this paper at this time.

Abstract

This Viewpoint presents the components of the payment model and the implementation challenges among the Center for Medicare and Medicaid Innovation, state Medicaid agencies, patients, and manufacturers.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kannarkat et al. (2024) studied this question.

synapsesocial.com/papers/68e68e7db6db643587615dabhttps://doi.org/10.1001/jama.2024.6224
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult2005 · 2,260 citations
  2. 2Consensus methods: characteristics and guidelines for use.1984 · 2,147 citations
  3. 3Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts2019 · 9 citations
  4. 4Development of a Severity Classification System for Sickle Cell Disease2020 · 46 citations
  5. 5Potential Consequences of Changing Disease Classifications2020 · 23 citations